Veterinary Medicines

Nobilis ND C2 lyophilisate for oculonasal suspension for chickens

Not authorised
  • Newcastle disease virus, strain C2, Live
Download as PDF

Product identification

Medicine name:
NOBILIS ND C2
Nobilis ND C2 lyophilisate for oculonasal suspension for chickens
Active substance:
  • Newcastle disease virus, strain C2, Live
Target species:
  • Chicken
Route of administration:
  • Oculonasal use
  • Nebulisation use

Product details

Active substance and strength:
  • Newcastle disease virus, strain C2, Live
    5.70
    50% Embryo Infective Dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for oculonasal suspension
Withdrawal period by route of administration:
  • Oculonasal use
    • Chicken
      • All relevant tissues
        no withdrawal period
  • Nebulisation use
    • Chicken
      • All relevant tissues
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD06
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Ireland
Package description:
  • Cardboard box with 1 vial of 500 doses.
  • Cardboard box with 1 vial of 5000 doses.
  • PET plastic boxes with 12 cups of 5000 doses
  • PET plastic boxes with 12 cups of 2500 doses
  • PET plastic boxes with 12 cups of 10000 doses
  • PET plastic boxes with 12 cups of 1000 doses
  • Cardboard box with 1 vial of 25000 doses.
  • Cardboard box with 1 vial of 2500 doses.
  • Cardboard box with 1 vial of 10000 doses.
  • Cardboard box with 1 vial of 1000 doses.
  • Cardboard box with 10 vials of 1000 doses.
  • Cardboard box with 10 vials of 10000 doses.
  • Cardboard box with 10 vials of 2500 doses.
  • Cardboard box with 10 vials of 25000 doses.
  • Cardboard box with 10 vials of 5000 doses.
  • Cardboard box with 10 vials of 500 doses.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10996/187/001
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0113/001

Documents

Combined File of all Documents

English (PDF)
Published on: 28/10/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."